1548-62-5 Usage
General Description
2-nitro-6-(trifluoromethyl)phenol, also known as NTMP, is a chemical compound with the molecular formula C7H4F3NO3. It is a yellow crystalline solid that is commonly used as an intermediate in the production of pharmaceuticals, dyes, and other organic compounds. NTMP is classified as a nitrophenol, which is a type of aromatic compound containing a nitro group (-NO2) and a hydroxyl group (-OH) attached to a phenyl ring. The trifluoromethyl group in NTMP provides enhanced stability and resistance to chemical reactions, making it a valuable building block in the synthesis of various complex molecules. Additionally, NTMP has antibacterial and antifungal properties, and is used in some industrial and agricultural applications for its biocidal effects. However, it is important to handle NTMP with care, as it is toxic and can cause irritation to the eyes, skin, and respiratory system if not handled properly.
Check Digit Verification of cas no
The CAS Registry Mumber 1548-62-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,4 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1548-62:
(6*1)+(5*5)+(4*4)+(3*8)+(2*6)+(1*2)=85
85 % 10 = 5
So 1548-62-5 is a valid CAS Registry Number.
1548-62-5Relevant articles and documents
HMOX1 inducers
-
Page/Page column 157, (2020/09/18)
The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.
NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
-
Page/Page column 135, (2008/06/13)
The present invention relates to novel compounds of formula (I) wherein W, n, X and W’ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION
-
, (2008/06/13)
The invention provides compounds according to formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia. Also provided are pharmaceutical compositions containing such compounds and processes for preparing some of the compounds of the invention.
